Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease

Summary

The purpose of this research study is to study the safety and efficacy of fenofibrate, an FDA-approved drug for high cholesterol and/or elevated triglycerides (fats), as a treatment for Huntington's disease (HD). Subjects who meet the entry criteria will be randomized (3:1) to either 145mg of fenofibrate or placebo.

Timeline

Start

2017-04-27

Primary completion

2021-08-31

Completion

2021-08-31

Drugs

Indications